Back to News
Market Impact: 0.25
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in Europe
Source: globenewswire.com
Patents & Intellectual PropertyHealthcare & Biotech
NuCana announced that the European Patent Office granted a composition-of-matter patent covering NUC-7738. The patent strengthens intellectual-property protection for the oncology-focused biotech company's drug candidate in Europe, though the release provided no clinical, financial, or commercial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
NCNA0.65
More News
- Walgreens owner nears $9 billion deal to sell Boots chain- WSJ
- Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
- Why is Toho stock volatile today?
- Lilly’s Foundayo shows cardiovascular safety in diabetes trial
- Nvidia is approaching a breakout level. Plus, what we want to see from Micron
- Some Oura IPO Investors Were Said to Push Back Citing Valuation